Dec 21, 2017
PolyPid Appoints Jacob Harel as Chairman of the Board of Directors
Dec 19, 2017
BioMarin Doses First Patient in Global GENEr8-1 Phase 3 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
Dec 15, 2017
Global Precision Medicine Market to Reach $141.70 Billion by 2026, Reports BIS Research
Dec 12, 2017
Global Chronic Kidney Disease (CKD) Drugs Market Forecast 2018-2028
Dec 12, 2017
Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs
Dec 11, 2017
Patented Medicine Prices Review Board explores possible changes to how it conducts business
Dec 11, 2017
Processa Pharmaceuticals Announces Reverse Stock Split and Launches New Website
Dec 06, 2017
CytRx Corporation Announces Filing of Key Provisional Patent Applications for Ultra-High Potency LADR(TM) Drug Candidates
Dec 05, 2017
Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report
Dec 04, 2017
Camargo CEO Meeting with Leading Companies in Japan, Korea, Taiwan, and India
Dec 04, 2017
Next Decade Generic String of Pearls Opportunities: Sustainability Assessment With Respect to Therapeutic Positioning, Reports Bharat Book Bureau
Dec 01, 2017
Notice to the media - Government of Canada officials will hold a media technical briefing on changes to drug price regulations
Nov 30, 2017
Next Decade Generic String of Pearls Opportunities 2017: Focus on Oncology, Cardiovascular, Respiratory, Gastroenterology, Psychiatry & Infectious Disease
Nov 30, 2017
New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices
Nov 29, 2017
Global High Throughput Process Development Market, 2025 - Increasing Public Health Awareness Resulting in Higher Demand for Effective Diagnosis and Treatment
Nov 28, 2017
Next Decade Generic String Of Pearls Opportunities: Sustainability Assessment With Respect To Therapeutic Positioning
Nov 28, 2017
Global Botanical and Plant-derived Drugs Markets, 2017-2022: Market will Grow from $29.4 Billion in 2017 to Approx. $39.6 Billion by 2022 with a CAGR of 6.1%
Nov 27, 2017
BioMarin Sells Second Priority Review Voucher for $125 Million
Nov 24, 2017
People Willing to Trade Treatment Efficacy for Reduced Side Effects in Cancer Therapies
Nov 22, 2017
As Prescription Drug Prices Soar, Financial Education Benefits Center Will Offer an Rx Discount Benefit